Three decades of data from the Global Burden of Disease Study were analyzed for trends in global, regional, and national ...

New podcasts from advocacy organization Phaware will highlight treatment advances in pulmonary hypertension tied to ...

Headquartered in New Brunswick, New Jersey, Johnson & Johnson (JNJ) researches and develops, manufactures, and sells various ...

Sotatercept-csrk reduced the risk of major morbidity and mortality events in adults with World Health Organization (WHO) Group 1 pulmonary arterial hypertension (PAH) functional class (FC) 3 or 4 at ...

ShareChronic diseases like diabetes, hypertension, cancer, and chronic obstructive pulmonary disease (COPD) affect millions ...

Winrevair (sotatercept-csrk) significantly reduced the risk of death, lung transplant, or hospitalization in people with PAH.

We recently published a list of 20 Stocks Insiders Were Selling In Q1 2025. In this article, we are going to take a look at ...

The prevalence of metabolic dysfunction–associated steatotic liver disease, chronic kidney disease, and obstructive sleep ...

A small, multi-country analysis of women of child-rearing age has found that these patients experience limits on activities ...

MADISON (WKOW) — UW Health is celebrating its 1,000th heart transplant recipient. Kourtney Zblewski was the recipient. She ...

For those interested in learning about leadership strategies and high-altitude ranching, the University of Wyoming Ranch ...

During the first quarter, seven insiders, including the CEO, COO, and CFO, sold approximately $53.02 million worth of Insmed shares at an average price of $73.79 per share. The stock now trades at $75 ...